Combinatorx, Incorporated is a biotechnology company based in Cambridge, MA, specializing in the development of innovative therapeutics. The organization focuses on leveraging advanced technologies to create novel drug candidates, particularly in the fields of immunology and oncology. By employing a unique approach to drug discovery, Combinatorx aims to address unmet medical needs and enhance treatment options for patients. Their commitment to research and development positions them at the forefront of biopharmaceutical advancements.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

10 Patents

#231 in Cambridge, MA

#1,773 in Massachusetts

#29,866 in US

#56,047 in the World

Cambridge, MA, United States of America

Combinatorx, Incorporated

Forward Citations = 203

18 inventors:

Curtis Keith (9 out of 11 patents)

Alexis Borisy (8 out of 14 patents)

Michael Andrew Foley (5 out of 14 patents)

4. Edward Roydon Jost-Price (5 out of 7 patents)

5. Palaniyandi Manivasakam (5 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Combinatorx, Incorporated. Retrieved from https://idiyas.com/company/combinatorx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]